Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: The role of cysteine peptidases and the NF-κB signaling pathway

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3297-3304

  Cameron, Pamela ^a,c   McGachy, Adrienne ^a   Anderson, Mary ^a   Paul, Andrew ^a   Coombs, Graham H ^b   Mottram, Jeremy C ^b   Alexander, James ^a   Plevin, Robin ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; ISOENZYME; JANUS KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

AMASTIGOTE; ANIMAL CELL; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELETION MUTANT; DNA BINDING; LEISHMANIA MEXICANA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 4344613395     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3297     Document Type: Article

References (54)

1. Alexander, J., A. R. Satoskar, and D. G. Russell. 1999. Leishmania species: models of intracellular parasitism. J. Cell Sci. 112:2993.
2. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
3. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. E. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
4. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
5. Gorak, P. M., C. R. Engwerda, and P. M. Kaye. 1998. Dendritic cells, but no macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28:687.
6. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541.
7. + T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 161:6156.
8. + T cells during initiation of infection. J. Exp. Med. 179:447.
9. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 185:515.
10. Kropf, P., R. Etges, L. Schopf, C. Chung, J. Sypek, and I. Muller. 1997. Characterisation of T cell-mediated responses in non-healing and healing Leishmania major infections in the absence of endogenous IL4. J. Immunol. 159:3434.
11. Jones, D. E., L. U. Buxbaum, and P. Scott. 2000. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165:364.
12. Weinheber, N., M. Wolfram, D. Harbecke, and T. Aebischer. 1998. Phagocytosis of Leishmania mexicana amastigotes by macrophage leads to a sustained suppression of IL-12 production. Eur. J. Immunol. 28:2467.
13. Yoshimoto, T., H. Nagase, T. Ishida, J. Inoue, and H. Nariuchi. 1997. Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-κB. Eur. J. Immunol. 27:3461.
14. Feng, G.-J., H. S. Goodridge, M. M. Harnett, X.-Q. Wei, A. V. Nikolaev, A. P. Higson, and F.-Y. Liew. 1999. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lioplysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targetting ERK MAP kinase. J. Immunol. 163:6403.
15. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141.
16. Mottram, J. C., A. E. Souza, J. E. Hutchison, R. Carter, M. J. Frame, and G. H. Coombs. 1996. Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc. Natl. Acad. Sci. USA 93:6008.
17. Alexander, J., G. H. Coombs, and J. C. Mottram. 1998. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J. Immunol.:6794.
18. Pollock, K. G., K. S. McNeil, J. C. Mottram, R. E. Lyons, J. M. Brewer, P. Scott, G. H. Coombs, and J. Alexander. 2003. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J. Immunol. 170:1746.
19. Hart, D. T. K., K. Vickerman, and G. H. Coombs. 1981. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Parasitology 82:345.
20. Bates, P. A., C. D. Robertson, L. Tetley, and G. H. Coombs. 1992. Axenic cultivation and characterisation of Leishmania mexicana amastigote-like forms. Parasitology 105:193.
21. Sanderson, S. J., K. G. Pollock, J. D. Hilley, M. Meldal, P. S. Hilaire, M. A. Juliano, L. Juliano, J. C. Mottram, and G. H. Coombs. 2000. Expression and characterization of a recombinant cysteine proteinase of Leishmania mexicana. Biochem. J. 347:383.
22. Laird, S. M., A. Graham, A. Paul, G. W. Gould, C. Kennedy, and R. Plevin. 1998. Tumour necrosis factor stimulates stress-activated protein kinases and the inhibition of DNA synthesis in cultures of bovine aortic endothelial cells. Cell. Signal. 10:473.
23. Cameron, P., D. Bingham, A. Paul, M. Pavelka, S. Cameron, D. Rotondo, and R. Plevin. 2002. Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor κB signaling, stimulated by Escherichia coli O157:H7 in Vero cells. Infect. Immun. 70:5370.
24. Mohrs, M., C. Holscher, and F. Brombacher. 2000. Interleukin4 receptor α-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection. Infect. Immun. 68:1773.
25. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon g or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
26. Satoskar, A., F. Brombacher, W. J. Dai, I. McInnes, F. Y. Liew, J. Alexander, and W. Walker. 1997. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis. J. Immunol. 159:5005.
27. Alexander, J., F. Brombacher, A. McGachy, A. N. McKenzie, W. Walker, and K. C. Carter. 2002. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection. Eur. J. Immunol. 32:2923.
28. Kopf, M., F. Brombacher, R. Kohler, G. Kienzle, K. H. Widmann, K. Lefrang, C. Humborg, B. Lederman, and W. Solbach. 1996. IL-4 deficient mice resist infection with Leishmania major. J. Exp. Med. 184:1127.
29. Ferguson, M. A., J. S. Brimacombe, S. Cottaz, R. A. Field, L. S. Guther, S. W. Homans, M. J. McConville, A. Mehlert, K. G. Milne, J. E. Ralton, et al. 1994. Glycosyl-phosphatidylinositol molecules of the parasite and the host. Parasitology 108(Suppl.):S45.
30. Peidrafita, D., L. Proudfoot, A. V. Nikolaev, D. Xu, W. Sands, G.-J. Feng, E. Thomas, J. Brewer, M. A. J. Ferguson, J. Alexander, et al. 1999. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans. Eur. J. Immunol. 29:235.
31. Buxbaum, L. U., J. E. Uzonna, M. H. Goldschmidt, and P. Scott. 2002. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur. J. Immunol. 32:3206.
32. Agilar Torretera, F., J. D. Laman, M. Van Meurs, L. Adorini, E. Maraille, and Y. Cartier. 2002. Endogenous interleukin-12 is critical for controlling the late but not the early stage of Leishmania mexicana infection in C57BL/6 mice. Infect. Immun. 70:5075.
33. Buxbaum, L.U., D. Hubert, G.H. Coombs, J. Alexander, J. C. Mottram, and P. Scott. 2003. CPB cysteine proteases of Leishmania mexicana inhibit host Th1 responses and protective immunity. J. Immunol. 171, 3711
34. Ghosh, S. M. J., and E. B. Kopp. 1998. NFκB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
35. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NFκB activity. Annu. Rev. Immunol. 18:621.
36. Naumann, M. 2000. Nuclear factor-κB activation and innate immune response in microbial pathogen infection. Biochem. Pharmacol. 60:1109.
37. Tato, C. M., and C. A. Hunter. 2002. Host-pathogen interactions: subversion and utilization of the NF-κB pathway during infection. Infect. Immun. 70:3311.
38. Dhib-Jalbut, S., J., H. Xia, Y. Rangaviggula, Y. Y. Fang, and, T. L. 1999. 1999. Failure of measles virus to activate nuclear factor-κB in neuronal cells: implications on the immune response to viral infections in the central nervous system. J. Immunol. 162:4024.
39. Akari, H., S. Bour, S. Kao, A. Adachi, and K. Strebel. 2001. The human immunodeficiency virus type I accessory protein Vpu induces apoptosis by suppressing the nuclear factor κB-dependent expression of antiapoptotic factors. J. Exp. Med. 194:1299.
40. Bour, S., C. Perrin, H. Akari, and K. Strebel. 2001. The human immunodeficient virus type 1 Vpu protein inhibits NF-κB activation by interfering with bTrCP-mediated degradation of IκB. J. Biol. Chem. 276:15920.
41. Oie, K. L., and D. J. Pickup. 2001. Cowpox virus and other members of the ortopoxvirus genus interfere with the regulation of NF-κB activation. Virology 288:175.
42. Klumpp, D. J., A. C. Weiser, S. Sengupta, S. G. Forrestal, R. A. Batler, and A. J. Schaeffer. 2001. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-κB. Infect. Immun. 69:6698.
43. Neish, A. S., A. T. Gewirtz, H. Zeng, A. N. Young, M. E. Hobert, V. Karmali, A. S. Rao, and J. L. Madara. 2000. Prokaryotic regulation of epithelial responses by inhibition of IκBα ubiquitination. Science 289:1560.
44. Revilla, Y., M. Callejo, J. M. Rodriguez, E. Culebras, M. L. Nogal, M. L. Salas, E. Vinuela, and M. Fresno. 1998. Inhibition of nuclear factor κB activation by a virus-encoded IκB-like protein. J. Biol. Chem. 273:5405.
45. Pahlevan, A. A., D. J. Wright, C. Andrews, K. M. George, P. L. Small, and B. M. Foxwell. 1999. The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-κB function. J. Immunol. 163:3923.
46. Shapira, S., K. Speirs, A. Gerstein, J. Caamano, and C. A. Hunter. Suppression of NF-κB activation by infection with Toxoplasma gondii. J. Infect. Dis. 185:S66, 2002.
47. Butcher, B. A., L. Kim, P. F. Johnson, and E. Y. Denkers. 2001. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. J. Immunol. 167:2193.
48. Trottein, F., S. Nutten, V. Angeli, P. Delerive, E. Teissier, A. Capron, B. Staels, and M. Capron. 1999. Schistosoma ansoni schistosomula reduce E-selectin and VCAM-1 expression TNF-α-stimulated lung microvascular endothelial cells by interfering with the NK-κB pathway. Eur. J. Immunol. 29:3691.
49. Ghosh, S., S. Bhattacharyya, M. Sirkar, Sa S.G., T. Das, D. Majumdar, S. Roy, and S. Majumdar. 2002. Leishmania donovani suppresses activated protein 1 and NF-κB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect. Immun. 70:6828.
50. Toledano, M. B., D. Ghosh, F. Trinh, and W. J. Leonard. 1993. N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-κB p50 and p65. Mol. Cell. Biol. 13:852.
51. Ganchi, P. A., S. C. Sun, W. C. Greene, and D. W. Ballard. 1992. I κB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell. 3:1339.
52. Padigel, U. M., J. Alexander, and J. P. Farrell. 2003. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J. Immunol. 171:3708.
53. Lu, H. T., D. D. Yang, M. Wysk, E. Gatti, I. Mellman, R. J. Davis, and R. A. Flavell. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. 18:1845.
54. Utsugi, M., K. Dobashi, T. Ishizuka, K. Endou, J. Hamuro, Y. Murata, T. Nakazawa, and M. Mori. 2003. c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. J. Immunol. 171:628.